Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pelareorep and Atezolizumab in Advanced Gastrointestinal Cancers
NCT07280377Phase 2Active, not recruiting
- Sponsor
- Oncolytics Biotech Inc.
- Start
- Oct 2021
- Primary completion
- Jul 2027
- Modality
- Oncolytic Viruses, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pelareorep in pancreatic cancer (PC), colorectal cancer (CRC), anal cancer, sponsored by Oncolytics Biotech Inc.. Started Oct 2021; status: active, not recruiting.
02
Drugs
pelareorep
03
Conditions
pancreatic cancer (PC)colorectal cancer (CRC)anal cancer
Beyond the preview
Go deeper on NCT07280377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07280377.